Skip to main content

Search : Conferences and Meetings

Sort by:

Clear Search
Course image
Linked Courses
Education Program, Marquee Sessions, Scientific Program, Scientific Symposia, Special-Interest Sessions, Spotlight Sessions, Trainee Activities and Services
Conferences and Meetings
2024 Annual Meeting - Invited Program
View Details
12/07/2024 To 12/14/2027
Level 3 (Subspecialty): Fellows developing general hematology expertise for board certification
Research - Basic Science Research - Biostatistics Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational
Course image
Linked Courses
Education Program, Marquee Sessions, Scientific Program, Scientific Symposia, Special-Interest Sessions, Spotlight Sessions, Trainee Activities and Services, Oral Abstracts
Conferences and Meetings
2024 Annual Meeting Invited Program + Oral Abstracts
View Details
12/07/2024 To 12/14/2027
Research - Basic Science Research - Biostatistics Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational
Course image
MapleLMS Implementation
Linked Courses
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster I, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster II, 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster I, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II, 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II, 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster I, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III, 636. Myelodysplastic Syndromes: Basic and Translational: Poster I, 636. Myelodysplastic Syndromes: Basic and Translational: Poster II, 636. Myelodysplastic Syndromes: Basic and Translational: Poster III, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster II, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster III, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster III, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster I, 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster II, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster I, 616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster II, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster I, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster II, 617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster III, 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster II, 637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster I
Conferences and Meetings
2024 Annual Meeting: Poster Bundle - Myeloid Malignancies
View Details
12/07/2024 To 12/14/2027
Acute myeloid leukemia (non-APL) Chronic myeloid leukemia Clonal myeloid disorders Myelodysplastic Syndromes Research - Basic Science Research - Clinical Research - Pre-Clinical Models Research - Translational Therapeutics - Immunotherapy Therapeutics - Targeted therapy Treatment-related acute myeloid leukemia
Course image
MapleLMS Implementation
Linked Courses
401. Blood Transfusion: Poster I, 401. Blood Transfusion: Poster II, 401. Blood Transfusion: Poster III, 602. Myeloid Oncogenesis: Basic: Poster I, 602. Myeloid Oncogenesis: Basic: Poster II, 602. Myeloid Oncogenesis: Basic: Poster III, 603. Lymphoid Oncogenesis: Basic: Poster I, 603. Lymphoid Oncogenesis: Basic: Poster II, 603. Lymphoid Oncogenesis: Basic: Poster III, 801. Gene Therapies: Poster I, 801. Gene Therapies: Poster II, 801. Gene Therapies: Poster III, 802. Chemical Biology and Experimental Therapeutics: Poster I, 802. Chemical Biology and Experimental Therapeutics: Poster II, 802. Chemical Biology and Experimental Therapeutics: Poster III, 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster I, 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster II, 803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster III
Conferences and Meetings
2024 Annual Meeting: Poster Bundle - Omics & Emerging Technologies
View Details
12/07/2024 To 12/14/2027
Artificial intelligence (AI); machine learning; an bleeding disorders classical hematology Clinical practice Clonal lymphoid disorders Clonal myeloid disorders Emerging technologies Hematopathology; laboratory medicine; images in he Hematopoietic stem cell transplantation and cellul Non-human populations - Animal models Plasma cell disorders Platelet disorders red cell disorders Research - Basic Science Research - Clinical Research - Population Science Research - Pre-Clinical Models Research - Translational Therapeutics - Biologics Therapeutics - Immunotherapy Therapeutics - Targeted therapy Transfusion medicine and apheresis
Course image
MapleLMS Implementation
Linked Courses
301. Platelets and Megakaryocytes: Basic and Translational: Poster I, 301. Platelets and Megakaryocytes: Basic and Translational: Poster II, 301. Platelets and Megakaryocytes: Basic and Translational: Poster III, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II, 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster I, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster II, 321. Coagulation and Fibrinolysis: Basic and Translational: Poster III, 322. Hemophilia A and B: Clinical and Epidemiological: Poster I, 322. Hemophilia A and B: Clinical and Epidemiological: Poster II, 322. Hemophilia A and B: Clinical and Epidemiological: Poster III, 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster I, 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster II, 331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster III, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II, 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III
Conferences and Meetings
2024 Annual Meeting: Poster Bundle - Thrombosis and Coagulation
View Details
12/07/2024 To 12/14/2027
bleeding disorders Health outcomes Platelet disorders Research - Basic Science Research - Clinical Research - Outcomes Research - Pre-Clinical Models Research - Translational Systems-based hematology Thrombotic disorders
Course image
MapleLMS Implementation
Linked Courses
101. Red Cells and Erythropoiesis, Excluding Iron: Poster I, 101. Red Cells and Erythropoiesis, Excluding Iron: Poster II, 101. Red Cells and Erythropoiesis, Excluding Iron: Poster III, 102. Iron Homeostasis and Biology: Poster I, 102. Iron Homeostasis and Biology: Poster II, 102. Iron Homeostasis and Biology: Poster III, 112. Thalassemia and Globin Gene Regulation: Poster I, 112. Thalassemia and Globin Gene Regulation: Poster II, 112. Thalassemia and Globin Gene Regulation: Poster III, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster II, 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster III, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II, 114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster I, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II, 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III
Conferences and Meetings
2024 Annual Meeting: Poster Bundle - Erythroid Development & Iron Metabolism
View Details
12/07/2024 To 12/14/2027
Clonal myeloid disorders Iron physiology and iron overload syndromes Normal iron physiology Normal red cell physiology Other inherited anemias Other topics in classical hematology Primary myelofibrosis red cell disorders Research - Basic Science Research - Biostatistics Research - Clinical Research - Outcomes Research - Population Science Research - Pre-Clinical Models Research - Translational Sickle cell disorders Thalassemias and other hemoglobin disorders Therapeutics - Biologics Therapeutics - Targeted therapy
Course image
MapleLMS Implementation
Linked Courses
901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I, 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II, 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster II, 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster III, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster II, 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster III, 904. Outcomes Research: Hemoglobinopathies: Poster I, 904. Outcomes Research: Hemoglobinopathies: Poster II, 904. Outcomes Research: Hemoglobinopathies: Poster III, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II, 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster I, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster II, 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster III, 907. Outcomes Research: Plasma Cell Disorders: Poster I, 907. Outcomes Research: Plasma Cell Disorders: Poster II, 907. Outcomes Research: Plasma Cell Disorders: Poster III, 908. Outcomes Research: Myeloid Malignancies: Poster I, 908. Outcomes Research: Myeloid Malignancies: Poster II, 908. Outcomes Research: Myeloid Malignancies: Poster III, 909. Education, Communication, and Workforce: Poster I, 909. Education, Communication, and Workforce: Poster II, 909. Education, Communication, and Workforce: Poster III
Conferences and Meetings
2024 Annual Meeting: Poster Bundle - Health Services and Outcomes Research
View Details
12/07/2024 To 12/14/2027
Clonal lymphoid disorders Clonal myeloid disorders Health outcomes Other acute myeloid leukemias Other lymphoid leukemias Research - Outcomes Research - Population Science Systems-based hematology
Course image
MapleLMS Implementation
Linked Courses
201. Granulocytes, Monocytes, and Macrophages: Poster I, 201. Granulocytes, Monocytes, and Macrophages: Poster II, 201. Granulocytes, Monocytes, and Macrophages: Poster III, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II, 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III, 701. Experimental Transplantation: Basic and Translational: Poster I, 701. Experimental Transplantation: Basic and Translational: Poster II, 701. Experimental Transplantation: Basic and Translational: Poster III, 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster I, 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster II, 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster III, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster I, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster II, 704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster III, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster II, 711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster III, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II, 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II, 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster II, 723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster III, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II, 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III
Conferences and Meetings
2024 Annual Meeting: Poster Bundle - Immune Regulation & Therapies
View Details
12/07/2024 To 12/14/2027
Acute Myeloid Leukemia classical hematology Clinical practice Clonal lymphoid disorders Clonal myeloid disorders Emerging technologies health disparities Hematopoietic stem cell transplantation and cellul Myelodysplastic Syndromes Myeloproliferative Neoplasms Non-human populations - Animal models Pharmacology Primary myelofibrosis Quality and safety red cell disorders Research - Basic Science Research - Clinical Research - Outcomes Research - Population Science Research - Pre-Clinical Models Research - Translational Therapeutics - Biologics Therapeutics - Immunotherapy Therapeutics - Targeted therapy Transfusion medicine and apheresis
Course image
Linked Courses
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I, 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II, 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster III, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster I, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II, 612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III, 614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I, 614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II, 614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster III, 618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I, 618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II, 618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III, 621. Lymphomas: Translational – Molecular and Genetic: Poster I, 621. Lymphomas: Translational—Molecular and Genetic: Poster II, 621. Lymphomas: Translational—Molecular and Genetic: Poster III, 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster I, 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster II, 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III, 624. Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Poster I, 624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Poster II, 624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Poster III, 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster I, 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster II, 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster III, 627. Aggressive Lymphomas: Clinical and Epidemiological: Poster I, 627. Aggressive Lymphomas: Clinical and Epidemiological: Poster II, 627. Aggressive Lymphomas: Clinical and Epidemiological: Poster III, 641. Chronic Lymphocytic Leukemias: Basic and Translational: Poster I, 641. Chronic Lymphocytic Leukemias: Basic and Translational: Poster II, 641. Chronic Lymphocytic Leukemias: Basic and Translational: Poster III, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster I, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II, 642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster III, 622. Lymphomas: Translational–Non-Genetic: Poster II, 622. Lymphomas: Translational–Non-Genetic: Poster III, 622. Lymphomas: Translational – Non-Genetic: Poster I
Conferences and Meetings
2023 Annual Meeting Poster Bundle - Lymphoid Malignancies
View Details
12/09/2023 To 12/16/2026